問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
范淞斌
下載
2025-09-15 - 2030-12-31
Condition/Disease
Changes in CDR-SB from the base period to week 72
Test Drug
trontinemab
Participate Sites8Sites
Recruiting8Sites
2024-07-01 - 2026-12-31
Participate Sites3Sites
Recruiting3Sites
2023-08-01 - 2025-01-31
Participate Sites2Sites
Not yet recruiting1Sites
Recruiting1Sites
2025-05-01 - 2043-05-01
Recruiting2Sites
2024-12-01 - 2024-12-02
2025-01-03 - 2028-12-31
2021-06-01 - 2028-12-31
Participate Sites4Sites
Recruiting4Sites
2024-03-01 - 2027-12-31
Participate Sites1Sites
2025-01-01 - 2031-12-31
Participate Sites10Sites
Recruiting10Sites
2024-04-01 - 2028-12-31
Participate Sites11Sites
Recruiting11Sites
全部
